Biotalys NV
BTLS.BR
| Exchange: | BR |
| Currency | Euro |
| ISIN: | BE0974386188 |
| Primary Ticker: | BTLS.BR |
| Fiscal Year End: | December |
| Sector: | Basic Materials |
| Industry: | Agricultural Inputs |
| Gic Sector: | Materials |
| Gic Group: | Materials |
| Gic Industry: | Chemicals |
| Gic Sub Industry: | Fertilizers & Agricultural Chemicals |
| Description: | Biotalys NV, an agricultural technology company, discovers and develops novel biological products in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; and BIOFUN-4 targeting oomycetes in fruits and vegetables. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium. |
| Address: | Buchtenstraat 11, Gent, Belgium, 9051 |
| Website: | https://www.biotalys.com |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 114245680 |
| Market Capitalization Mln: | 114.24 |
| EBITDA: | -15094000 |
| Wall Street Target Price: | 7.5 |
| Book Value: | 0.60 |
| Earnings Share: | -0.51 |
| Most Recent Quarter: | 2024-06-30 |
| Return On Assets TTM: | -0.27 |
| Return On Equity TTM: | -0.59 |
| Revenue TTM: | 2949000 |
| Revenue Per Share TTM: | 0.09 |
| Gross Profit TTM: | 2949000 |
| Diluted Eps TTM: | -0.51 |
Valuation
| Price Sales TTM: | 695.11 |
| Price Book MRQ: | 5.83 |
| Enterprise Value: | 102940564 |
| Enterprise Value Ebitda: | -8.68 |
Shares
| Shares Outstanding: | 37457600 |
| Shares Float: | 7763032 |
| Percent Insiders: | 47.95 |
| Percent Institutions: | 23.43 |
Technicals
| Beta: | 0.96 |
| 52 Week High: | 5.34 |
| 52 Week Low: | 1.62 |
| 50 Day MA: | 3.12 |
| 200 Day MA: | 3.15 |
Earnings
| Report Date: | 2025-04-23 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2023-02-28 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.74 |
| Eps Difference: | -0.74 |
| Report Date: | 2022-08-19 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.32 |
| Eps Difference: | -0.32 |
| Report Date: | 2022-03-11 |
| Date: | 2021-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.55 |
| Eps Difference: | -0.55 |
| Report Date: | 2021-12-08 |
| Date: | 2021-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.11 |
| Eps Difference: | -0.11 |
| Report Date: | 2021-06-23 |
| Date: | 2021-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.36 |
| Eps Difference: | -0.36 |
| Date: | 2022-12-31 |
| Period: | +1y |
| Growth: | -0.34 |
| Earnings Estimate Year Ago Eps: | -0.41 |
| Earnings Estimate Growth: | -0.34 |
| Revenue Estimate Avg: | 2949000000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Growth: | 1477.19 |
| Eps Trend7days Ago: | -0.40 |
| Eps Trend30days Ago: | -0.40 |
| Eps Trend60days Ago: | -0.40 |
| Eps Trend90days Ago: | -0.40 |
| Date: | 2021-12-31 |
| Revenue Estimate Avg: | 1995000.00 |
| Revenue Estimate High: | 2000000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Eps Trend7days Ago: | -0.41 |
| Eps Trend30days Ago: | -0.41 |
| Eps Trend60days Ago: | -0.41 |
| Eps Trend90days Ago: | -0.41 |
| Date: | 2021-06-30 |
| Period: | +1q |
| Date: | 2021-03-31 |
| Date: | 2022-12-31 |
| Eps Actual: | -1.0 |
| Date: | 2021-12-31 |
| Eps Actual: | -1.0 |